Decision Date2020-07-17
Product CodeMQL
Advisory CommitteeOB
DecisionSubstantially Equivalent
Device Summary
Synvitro Hyadase is a medical device manufactured by Origio A/S, A Coopersurgical Company. It received FDA 510(k) clearance on 2020-07-17 under approval number K200680. The device is classified under product code MQL. It was reviewed by the OB advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the Synvitro Hyadase?
Synvitro Hyadase is a medical device that received FDA 510(k) clearance on 2020-07-17. It is manufactured by Origio A/S, A Coopersurgical Company. The 510(k) number is K200680.
When was Synvitro Hyadase approved by the FDA?
Synvitro Hyadase received FDA 510(k) clearance on 2020-07-17, under approval number K200680.
What company makes Synvitro Hyadase?
Synvitro Hyadase is manufactured by Origio A/S, A Coopersurgical Company.
What is the FDA product code for Synvitro Hyadase?
The FDA product code for Synvitro Hyadase is MQL.
Related Devices (Code: MQL)
K160864Cryotop Vitrification Kit and Cryotop Thawing KitKitazato Biopharma Co., Ltd.
K153478Sydney IVF Gamete BufferWilliam A. Cook Australia Pty. , Ltd.
K160863PBS(-), Phosphate Buffered SalineKitazato Biopharma Co., Ltd.
K153267ORIGIO Gradient 100, ORIGIO Gradient 90, ORIGIO Gradient 40/80, ORIGIO Sperm WashOrigio A/S
K152717Sydney IVF Blastocyst Cryopreservation Kit, Sydney IVF Blastocyst Thawing KitWilliam A. Cook Australia Pty. , Ltd.
K152682Sydney IVF Cryopreservation Kit, Sydney IVF Thawing KitWillian A. Cook Australia Pty, Ltd.
Official Source
View on FDA Database →
Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.